Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response.

Author： Sikiric P.   Seiwerth S.   Brcic L.   Blagaic A.   Zoricic I.   Sever M.   Klicek R.   Radic B.   Keller N.   Sipos K.   Jakir A.   Udovicic M.   Tonkic A.   Kokic N.   Turkovic B.   Mise S.   Anic T.  

Publisher： Springer Publishing Company

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.14, Iss.5-6, 2006-12, pp. : 214-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157

By  

Current Pharmaceutical Design, Vol. 19, Iss. 1, 2013-01 ,pp. : 76-83

Bentham Science Publishers

Access to resources Recommend Favorite

Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157

By  

Current Medicinal Chemistry, Vol. 19, Iss. 1, 2012-01 ,pp. : 126-132

Bentham Science Publishers

Access to resources Recommend Favorite

Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract

By  

Current Pharmaceutical Design, Vol. 17, Iss. 16, 2011-06 ,pp. : 1612-1632

Bentham Science Publishers

Access to resources Recommend Favorite

Stable Gastric Pentadecapeptide BPC 157-NO-system Relation

By  

Current Pharmaceutical Design, Vol. 20, Iss. 7, 2014-02 ,pp. : 1126-1135

Bentham Science Publishers

Access to resources Recommend Favorite

Revised Robert's Cytoprotection and Adaptive Cytoprotection and Stable Gastric Pentadecapeptide BPC 157. Possible Significance and Implications for Novel Mediator

By  

Current Pharmaceutical Design, Vol. 16, Iss. 10, 2010-04 ,pp. : 1224-1234

Bentham Science Publishers

Access to resources Recommend Favorite